{{Rsnum
|rsid=4848143
|Chromosome=2
|position=121054648
|Orientation=plus
|GMAF=0.4798
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.8 | 44.2 | 46.9
| HCB | 21.2 | 54.7 | 24.1
| JPT | 26.5 | 46.9 | 26.5
| YRI | 93.8 | 5.5 | 0.7
| ASW | 68.4 | 28.1 | 3.5
| CHB | 21.2 | 54.7 | 24.1
| CHD | 20.2 | 47.7 | 32.1
| GIH | 22.8 | 48.5 | 28.7
| LWK | 83.6 | 16.4 | 0.0
| MEX | 5.2 | 58.6 | 36.2
| MKK | 64.1 | 28.8 | 7.1
| TSI | 6.9 | 47.1 | 46.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}